ACE2 levels are altered in comorbidities linked to severe outcome in COVID-19
View ORCID ProfileValur Emilsson, View ORCID ProfileElias F Gudmundsson, View ORCID ProfileThor Aspelund, View ORCID ProfileBrynjolfur G Jonsson, View ORCID ProfileAlexander Gudjonsson, View ORCID ProfileLenore J. Launer, View ORCID ProfileJohn R Lamb, View ORCID ProfileValborg Gudmundsdottir, View ORCID ProfileLori L Jennings, View ORCID ProfileVilmundur Gudnason
doi: https://doi.org/10.1101/2020.06.04.20122044
Valur Emilsson
1Icelandic Heart Association, Holtasmari 1, IS-201 Kopavogur, Iceland
2Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland
Elias F Gudmundsson
1Icelandic Heart Association, Holtasmari 1, IS-201 Kopavogur, Iceland
Thor Aspelund
1Icelandic Heart Association, Holtasmari 1, IS-201 Kopavogur, Iceland
Brynjolfur G Jonsson
1Icelandic Heart Association, Holtasmari 1, IS-201 Kopavogur, Iceland
Alexander Gudjonsson
1Icelandic Heart Association, Holtasmari 1, IS-201 Kopavogur, Iceland
Lenore J. Launer
3Laboratory of Epidemiology and Population Sciences, Intramural Research Program, National Institute on Aging, Bethesda, MD 20892-9205, USA
John R Lamb
4GNF Novartis, 10675 John Jay Hopkins Drive, San Diego, CA 92121, USA.
Valborg Gudmundsdottir
1Icelandic Heart Association, Holtasmari 1, IS-201 Kopavogur, Iceland
2Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland
Lori L Jennings
5Novartis Institutes for Biomedical Research, 22 Windsor Street, Cambridge, MA 02139, USA
Vilmundur Gudnason
1Icelandic Heart Association, Holtasmari 1, IS-201 Kopavogur, Iceland
2Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland
Article usage
Posted June 05, 2020.
ACE2 levels are altered in comorbidities linked to severe outcome in COVID-19
Valur Emilsson, Elias F Gudmundsson, Thor Aspelund, Brynjolfur G Jonsson, Alexander Gudjonsson, Lenore J. Launer, John R Lamb, Valborg Gudmundsdottir, Lori L Jennings, Vilmundur Gudnason
medRxiv 2020.06.04.20122044; doi: https://doi.org/10.1101/2020.06.04.20122044
ACE2 levels are altered in comorbidities linked to severe outcome in COVID-19
Valur Emilsson, Elias F Gudmundsson, Thor Aspelund, Brynjolfur G Jonsson, Alexander Gudjonsson, Lenore J. Launer, John R Lamb, Valborg Gudmundsdottir, Lori L Jennings, Vilmundur Gudnason
medRxiv 2020.06.04.20122044; doi: https://doi.org/10.1101/2020.06.04.20122044
Subject Area
Subject Areas
- Addiction Medicine (358)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2701)
- Dermatology (231)
- Emergency Medicine (407)
- Epidemiology (12343)
- Forensic Medicine (10)
- Gastroenterology (774)
- Genetic and Genomic Medicine (4186)
- Geriatric Medicine (394)
- Health Economics (690)
- Health Informatics (2708)
- Health Policy (1012)
- Hematology (366)
- HIV/AIDS (869)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (447)
- Neurology (3974)
- Nursing (216)
- Nutrition (587)
- Oncology (2093)
- Ophthalmology (597)
- Orthopedics (245)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (76)
- Pathology (474)
- Pediatrics (1137)
- Primary Care Research (464)
- Public and Global Health (6602)
- Radiology and Imaging (1432)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (347)
- Surgery (458)
- Toxicology (56)
- Transplantation (192)
- Urology (170)